This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Urodelia, Hastim. Active years: 2016-2023.
Company Filing History:
Years Active: 2016-2023
Title: Nicole Rouquet: Innovator in Cancer Vaccine Development
Introduction
Nicole Rouquet is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of cancer treatment through her innovative work on autologous cancer vaccines. With a total of 3 patents to her name, Rouquet is recognized for her dedication to advancing medical science.
Latest Patents
One of her latest patents focuses on autologous cancer vaccines. This invention involves a method for producing a cancer vaccine by extracting proteins from a serum or plasma sample obtained from a patient suffering from cancer. The extracted proteins are then brought into contact with particles of hydroxyapatite and/or tricalcium phosphate. Another notable patent pertains to a hydroxyapatite powder that has undergone sintering at temperatures between 400°C and 600°C. This powder is used in compositions for anti-tumor auto-vaccines, particularly for treating various types of tumors, including osteosarcoma and melanoma.
Career Highlights
Throughout her career, Nicole Rouquet has worked with several companies, including Urodelia and Hastim. Her work has been instrumental in developing innovative solutions for cancer treatment, showcasing her commitment to improving patient outcomes.
Collaborations
Nicole has collaborated with notable professionals in her field, including Patrick Frayssinet and Daniel Ciocca. These collaborations have further enhanced her research and development efforts in cancer therapies.
Conclusion
Nicole Rouquet stands out as a dedicated inventor in the realm of cancer vaccine development. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving treatment options for cancer patients.